IP Library Patent Application 19027897
Patent Application
App. No. 19/027,897

HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/027,897
Abstract

Disclosed are compositions comprising a non-homogenized chorionic matrix, a homogenized amniotic matrix and a homogenized UC (UC) matrix, wherein the non-homogenized chorionic matrix comprises viable cells. Disclosed are methods of making the compositions disclosed herein comprising preparing a non-homogenized chorionic matrix, preparing a homogenized amniotic matrix, preparing a homogenized UC matrix, and combining the non-homogenized chorionic matrix, the non-homogenized chorionic matrix, and the homogenized UC matrix. Disclosed are methods of treating a tissue injury or chronic pain comprising administering any of the disclosed compositions to an area of a subject comprising a tissue injury.

Claims (24)

1 - 46 . (canceled)

47 . A composition comprising a minced chorionic matrix and a homogenized umbilical cord matrix, wherein the minced chorionic matrix comprises viable cells, wherein the composition does not comprise trophoblasts.

48 . The composition of claim 47 , wherein the homogenized umbilical cord matrix is devitalized.

49 . The composition of claim 47 , wherein the chorionic matrix and homogenized umbilical cord matrix are from the same donor.

50 . The composition of claim 47 , further comprising homogenized amniotic matrix.

51 . The composition of claim 50 , wherein the homogenized amniotic matrix is devitalized.

52 . The composition of claim 50 , wherein at least two of the chorionic matrix, homogenized amniotic matrix, and homogenized umbilical cord matrix are from the same donor.

53 . A composition comprising isolated, viable chorionic cells, a homogenized amniotic matrix, and a homogenized umbilical cord matrix, wherein the composition does not comprise trophoblasts.

54 . The composition of claim 53 , wherein the homogenized amniotic matrix and/or the homogenized umbilical cord matrix are devitalized.

55 . The composition of claim 53 , wherein the homogenized amniotic matrix and homogenized umbilical cord matrix are derived from the same donor.

56 . The composition of claim 53 , further comprising a chorionic matrix.

57 . The composition of claim 56 , wherein the chorionic matrix is non-homogenized.

58 . The composition of claim 56 , wherein the chorionic matrix is minced.

59 . The composition of claim 58 , wherein the minced chorionic matrix comprises native, viable cells.

60 . The composition of claim 56 , wherein at least two of the chorionic matrix, homogenized amniotic matrix and homogenized umbilical cord matrix are from the same donor.

61 . A method of treating a tissue injury or inflammation in a subject in need thereof, the method comprising administering to the tissue injury or region of inflammation a composition comprising:

a. a minced chorionic matrix, a homogenized amniotic matrix, and a homogenized umbilical cord matrix, wherein the minced chorionic matrix comprises viable cells, wherein the composition does not comprise trophoblasts;

b. isolated, viable chorionic cells, a homogenized amniotic matrix, and a homogenized umbilical cord matrix, wherein the composition does not comprise trophoblasts; or

c. a minced chorionic matrix and a homogenized UC matrix, wherein the minced chorionic matrix comprises viable cells, wherein the composition does not comprise trophoblasts or an amniotic matrix.

62 . The method of claim 61 , wherein the tissue injury or inflammation is osteoarthritis, cartilage repair, meniscus repair, intervertebral disc repair, plantar fasciitis, carpal tunnel, tendonitis, synovitis, ruptured or torn Achilles tendon, critical limb ischemia, ulcers, pyoderma gangrenosum, epidermolysis bullosa, surgical adhesions, plastic surgery or other wounds.

63 . The method of claim 61 , wherein the composition is administered by injecting the tissue injury or inflammation with the composition, topically applying the composition to the tissue injury or inflammation, or implanting the composition at the tissue injury or inflammation.

64 . The composition of claim 61 , wherein the homogenized amniotic matrix and/or the homogenized umbilical cord matrix are devitalized.

65 . The composition of claim 61 , wherein the chorionic matrix, the homogenized umbilical cord matrix, and/or the homogenized amniotic matrix are from the same donor.

66 . The composition of claim 61 , wherein the chorionic matrix is minced and comprises native, viable cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2025
From: SINCLAIR, STEVEN MICHAEL; DANILKOVITCH, ALLA; SATHYAMOORTHY, MALATHI; KUANG, JIN-QIANG; DHALL, SANDEEP; LIU, YISHAN; MELCHIORRI, ANTHONY JOHN; MOORMAN, MATTHEW ROBERT; LO MORIELLO, MENA SCHIANO; LERCH, ANNE ALLGOOD
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 070034/0467 →